Trump's Tariffs Leave Pharmaceutical Products Untouched for the Time Being

In a recent turn of events, pharmaceutical products have been excluded from the latest round of tariffs imposed by the Trump administration. This decision has provided a temporary reprieve for the drug industry, which has been closely monitoring the evolving trade landscape amid ongoing discussions about tariffs on various imports.

Continue reading